Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott EAS Sales Offset First Quarter Decline In Pediatric Nutritionals

This article was originally published in The Tan Sheet

Executive Summary

EAS has emerged as a strong contributor to Abbott's Ross adult nutritionals business

You may also be interested in...



North Castle sells Enzymatic Therapy to Nature’s Way

Springville, Utah-based herbal and natural product manufacturer Nature's Way acquires natural medicine and supplement firm Enzymatic Therapy under an Oct. 9 agreement with the North Castle Partners private equity firm, Enzymatic Therapy's majority shareholder. Green Bay, Wis.-based Enzymatic Therapy says Oct. 17 that all other shareholders approved the sale, which will close pending regulatory approvals. North Castle also was the majority investor in Naked Juice when PepsiCo acquired it in 2007 (1"The Tan Sheet" Nov. 27, 2007, In Brief). The Greenwich, Conn.-based firm also owned controlling interest in the EAS sports nutrition company when Abbott Labs acquired it in 2004, and it was part of the fund with majority investment when Leiner was sold in bankruptcy court (2"The Tan Sheet" April 18, 2005, p. 15 and 3"The Tan Sheet" June 9, 2008, p. 3)

North Castle sells Enzymatic Therapy to Nature’s Way

Springville, Utah-based herbal and natural product manufacturer Nature's Way acquires natural medicine and supplement firm Enzymatic Therapy under an Oct. 9 agreement with the North Castle Partners private equity firm, Enzymatic Therapy's majority shareholder. Green Bay, Wis.-based Enzymatic Therapy says Oct. 17 that all other shareholders approved the sale, which will close pending regulatory approvals. North Castle also was the majority investor in Naked Juice when PepsiCo acquired it in 2007 (1"The Tan Sheet" Nov. 27, 2007, In Brief). The Greenwich, Conn.-based firm also owned controlling interest in the EAS sports nutrition company when Abbott Labs acquired it in 2004, and it was part of the fund with majority investment when Leiner was sold in bankruptcy court (2"The Tan Sheet" April 18, 2005, p. 15 and 3"The Tan Sheet" June 9, 2008, p. 3)

North Castle sells Enzymatic Therapy to Nature’s Way

Springville, Utah-based herbal and natural product manufacturer Nature's Way acquires natural medicine and supplement firm Enzymatic Therapy under an Oct. 9 agreement with the North Castle Partners private equity firm, Enzymatic Therapy's majority shareholder. Green Bay, Wis.-based Enzymatic Therapy says Oct. 17 that all other shareholders approved the sale, which will close pending regulatory approvals. North Castle also was the majority investor in Naked Juice when PepsiCo acquired it in 2007 (1"The Tan Sheet" Nov. 27, 2007, In Brief). The Greenwich, Conn.-based firm also owned controlling interest in the EAS sports nutrition company when Abbott Labs acquired it in 2004, and it was part of the fund with majority investment when Leiner was sold in bankruptcy court (2"The Tan Sheet" April 18, 2005, p. 15 and 3"The Tan Sheet" June 9, 2008, p. 3)

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS098076

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel